Clinical Trials Sponsored by Bicara Therapeutics
Total 6432 results
-
Aprea TherapeuticsTerminatedMyelodysplastic Syndromes | MDSUnited States
-
Centrexion TherapeuticsCompletedOsteoarthritis, KneeUnited States
-
Akebia TherapeuticsCompletedAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Korea, Republic of, Portugal, Russian Federation, Ukraine, Poland, Argentina, Brazil, Germany, Mexico
-
Akebia TherapeuticsCompletedAnemia | End Stage Renal DiseaseUnited States
-
Corcept TherapeuticsActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States, Belgium, Canada, Italy, Spain
-
Silverback TherapeuticsActive, not recruitingHER2 Positive Solid TumorsUnited States, Korea, Republic of, Australia
-
Akebia TherapeuticsCompletedChronic Kidney DiseaseUnited States
-
United TherapeuticsCompletedAn Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionKorea, Republic of, United States, Australia, Austria, Taiwan, China, Israel, Canada, India, Germany, Singapore, United Kingdom, Brazil, Italy, Netherlands, Argentina, Sweden, Chile, Denmark, France, Greece, Mexico, Poland
-
Audentes TherapeuticsTerminatedCrigler-Najjar SyndromeIsrael, United States, United Kingdom
-
Blade TherapeuticsCompleted
-
Pendulum TherapeuticsTerminatedType 2 Diabetes MellitusIreland
-
Veralox TherapeuticsCompletedSafety and Tolerability in Healthy VolunteersUnited States
-
Syndesi TherapeuticsTerminatedCognitive DeclineUnited Kingdom, Germany
-
Elevar TherapeuticsCompleted
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
HiFiBiO TherapeuticsCompleted
-
Cartesian TherapeuticsCompleted
-
HiFiBiO TherapeuticsCompleted
-
CytomX TherapeuticsCompletedLymphoma | Solid TumorUnited States, Netherlands, Poland, Spain, Ukraine, United Kingdom
-
Corcept TherapeuticsCompleted
-
Sage TherapeuticsCompletedSevere Postpartum DepressionUnited States
-
Allergy TherapeuticsCompleted
-
PTC TherapeuticsCompleted
-
Cadent TherapeuticsCompleted
-
Tarveda TherapeuticsCompletedNeuroendocrine Tumors | Neuroendocrine Carcinoma | Carcinoma, Small Cell LungUnited States, United Kingdom
-
Aptevo TherapeuticsWithdrawn
-
Amicus TherapeuticsCompletedFabry DiseaseUnited Kingdom, United States
-
Alaunos TherapeuticsTerminatedDiffuse Intrinsic Pontine Glioma | Pediatric Brain TumorUnited States
-
TR TherapeuticsCompleted
-
Heron TherapeuticsCompletedPostoperative PainUnited States
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompletedGlioblastoma Multiforme | Anaplastic OligoastrocytomaUnited States
-
Nektar TherapeuticsCompletedOsteoarthritis of the KneeUnited States
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Atacama TherapeuticsActive, not recruitingHyperhidrosis | Palmar HyperhidrosisUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
AKARI TherapeuticsTerminatedParoxysmal Nocturnal HemoglobinuriaPoland
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
Aptevo TherapeuticsTerminatedPsoriasis | Ulcerative ColitisAustralia
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States, Canada, India, United Kingdom, Spain, Israel, Australia, Belgium, France, Austria, China, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Sweden
-
vTv TherapeuticsTerminatedAlzheimer's DiseaseUnited States, Australia, Canada, South Africa, United Kingdom, Ireland, New Zealand
-
Cyclerion TherapeuticsTerminated
-
Cadent TherapeuticsWithdrawnSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8 | Spinocerebellar Ataxia Type 17 | ARCA1 - Autosomal Recessive...United States
-
Aelix TherapeuticsCompleted